Stroke and TIA: Comprehensive Study Notes
Stroke and TIA: Comprehensive Study Notes
Overview: TIA vs. stroke
TIA = a transient blockage that acts as a warning shot; symptoms resolve and blood flow returns, but risk factors persist.
Stroke = a persistent blockage or bleed causing ongoing brain injury if not treated.
TIAs are temporary ischemic events; they’re often a precursor to an actual stroke if risk factors aren’t managed.
In the talk, TIAs are described as temporary and exact same signs as a stroke, but duration distinguishes them.
Key statistic given: about 85% of people with a TIA will have a stroke within the next 30 days.
Signs and quick differentiation (FAST/BFAST concepts)
Slurred speech (dysarthria) and unilateral weakness are classic stroke signs.
Facial droop, arm weakness, leg weakness, speech disturbances, and balance/eye issues are all possible.
Vision changes can occur but retinal occlusion is more typical for certain visual presentations.
In stroke vs TIA, duration and reversibility are the main distinctions; signs point to brain areas involved.
Ischemic vs hemorrhagic stroke basics
Ischemic strokes are due to a blockage; hemorrhagic strokes due to bleeding.
Early mortality risk is higher when the backward supply to the brain is compromised (like basilar region) because there’s typically a single supply to that brain region.
Most strokes (in general practice) are ischemic, but hemorrhages require different urgent management.
Brain blood supply and localization cues
Circle of Willis and major arteries feed the brain; internal carotid arteries (ICAs) feed the circle of Willis and the front of the brain; posterior circulation involves the basilar system.
The right hemisphere stroke typically produces left-sided symptoms (contralateral control); the left hemisphere stroke typically produces right-sided symptoms.
An important rule: the back of the brain (posterior circulation) can produce different signs and may be associated with higher mortality if blood supply is compromised due to limited collateral flow (basilar area).
The location of deficits (frontal lobe vs parietal vs occipital vs brainstem) helps localize the stroke.
Anatomy quick refresher (key areas and functions)
Frontal lobe: motor control (motor strip).
Cerebellum: coordination (ataxia).
Parietal lobe: sensation and perception.
Occipital lobe: vision.
Wernicke’s area: receptive language (understanding).
Broca’s area: expressive language (speaking, producing words).
Brainstem/cerebellar connections modulate cranial nerve function and autonomic control.
Aphasia and language deficits
Broca’s (expressive) aphasia: can understand but cannot speak fluently; often phrases are telegraphic; associated with frontal lobe injury.
Wernicke’s (receptive) aphasia: speech fluent but nonsensical; unable to understand, often cannot follow commands.
Global aphasia: extensive damage; both comprehension and expression are poor.
Extinction/neglect: contralateral sensory neglect when attention to one side is reduced; tested by bilateral stimulation.
Language laterality: left hemisphere is dominant for language in most right-handed individuals; right hemisphere contributes to emotional control and some nonverbal aspects.
Motor, sensory, and coordination signs
Motor: weakness and/or drift on one side due to frontal lobe involvement.
Sensory: diminished sensation on one side; tested by comparing sides.
Limb ataxia: lack of coordination (often a cerebellar sign); not usually in the same limb as motor weakness unless there’s extensive involvement.
Cerebellar signs: truncal ataxia, gait disturbances; vertigo can be central (cerebellar) or peripheral (ear-related); acute onset vertigo always consider stroke until proven otherwise.
Facial palsy: one-sided weakness; the lower face shows contralateral weakness due to facial nerve innervation; forehead often has bilateral innervation, so upper face may be preserved on the affected side in facial weakness.
Gaze and eye movements: cranial nerves III, IV, VI tested via tracking, lateral gaze, and responses; changes here indicate brainstem or cortical involvement.
Visual and perceptual signs
Quadrantanopia or hemianopia can occur depending on lesion location (contralateral field deficits are common).
Cortical blindness can occur with occipital involvement; brain can sometimes fill in missing information, so patients may not notice field loss immediately.
Retinal occlusion vs cortical visual loss: signs help determine where the damage is in the visual pathway.
Vertigo and cranial nerve signs
Central vertigo (cerebellar) carries higher stroke risk and mortality than peripheral vertigo; acute onset vertigo warrants stroke workup.
Cranial nerve deficits provide a map to brainstem involvement (CN III–XII signs are used to localize lesions).
Doll’s eye phenomenon (oculocephalic reflex) and other brainstem signs help assess brainstem integrity.
Blood pressure, diabetes, and risk factors in stroke
Blood pressure elevations are common in acute stroke; management aims to avoid further injury while maintaining cerebral perfusion.
Chronic hypertension is a major risk factor for both ischemic and hemorrhagic strokes; tight, long-term control helps reduce risk.
Diabetes management: does not reverse earlier damage but helps prevent further progression and new events.
Dyslipidemia (LDL/HDL) management and lifestyle changes (e.g., Mediterranean diet) are emphasized for vascular health.
Smoking and substance use (including certain medications and hormonal therapies) increase stroke risk; birth control and hormones can elevate risk in some individuals.
Risk scoring and decision-making in the clinic
ABCD2 score (for TIA risk stratification):
A = Age ≥ 60 years → 1 point
B = Blood pressure at presentation ≥ 140/90 mmHg → 1 point
C = Clinical features: unilateral weakness (2 points); speech impairment without weakness (1 point)
D = Duration of symptoms: ≥ 60 minutes (2 points); 10–59 minutes (1 point)
Diabetes mellitus → 1 point
Total range: 0–7. Higher scores indicate greater short-term stroke risk; used to guide outpatient vs inpatient management and urgent workup.
CHADS2 (atrial fibrillation stroke risk):
C = Congestive heart failure (CHF)
H = Hypertension
A = Age ≥ 75 years
D = Diabetes mellitus
S = Stroke/TIA previously (2 points)
Total score guides anticoagulation decisions in AF patients (alternative scoring schemes like CHA2DS2-VASc exist in practice).
Neuro exam and how it’s taught (NIHSS-style testing in this lecture)
Core idea: assess both language and non-language functions; combine neuro signs to estimate stroke severity.
Level of consciousness: arousal, orientation, and ability to follow commands.
Best language and dysarthria: ability to understand and articulate; differentiate aphasia vs dysarthria.
Visual fields and gaze: visual neglect and cranial nerve function.
Facial palsy: symmetry of smile and eyebrow movement; lower face weakness often more pronounced than upper face.
Motor arm and leg: drift and strength in each limb; use standardized positioning (e.g., 45-degree arm hold, 30-degree leg hold).
Limb ataxia: aim to detect cerebellar coordination problems.
Sensory: compare sensation on both sides.
Best language: assess comprehension and expression with pictures and commands.
Extinction and neglect: bilateral stimulation to identify neglect on one side.
Finally, practice and interpretation: the examiner should adapt to patient ability and provide clear, one-step commands when needed; avoid overwhelming the patient and tailor to individual comprehension level.
Note on exam approach: use visual cues and simple instructions for patients with aphasia or cognitive impairment; test comprehension first, then execution.
Imaging, diagnosis, and escalation of care
Imaging modalities:
CT Head (non-contrast) to exclude hemorrhage; appears white on CT as bone and dense tissue.
CT Angiography (CTA) to assess vessel stenosis or occlusion; contrast-based.
MRI (diffusion-weighted imaging) for more sensitivity in some cases; not always available.
Ultrasound/duplex for carotid stenosis assessment.
Diffusion and perfusion concepts: diffusion CT/MRI can reveal early ischemic changes; perfusion imaging helps identify potentially salvageable tissue (penumbra).
Endovascular therapy: thrombectomy for large vessel occlusion (LVO) within a time window; effectiveness depends on tissue at risk (penumbra) and time since onset.
Tissue plasminogen activator (tPA) vs tenecteplase (TNK):
Alteplase (rt-PA) dosing commonly cited as a 0.9 mg/kg total dose (max 90 mg) with 10% given as a bolus and the remainder infused over 60 minutes; dosing and timing are time-critical.
Tenecteplase (TNK) is a single bolus, dose often cited around 0.25 mg/kg (max ~25 mg); quicker administration and certain practical advantages in some settings.
In rural or resource-limited areas, TNK can enable earlier reperfusion without the need for infusion setups.
Blood pressure management around thrombolysis
Before thrombolysis, blood pressure must be within target ranges (varies by protocol; common thresholds include systolic < 185 mmHg and diastolic < 110 mmHg to proceed with tPA in many guidelines).
After thrombolysis, blood pressure is typically kept below roughly 180/105 mmHg for the first 24 hours to minimize hemorrhagic risk while maintaining perfusion.
Antithrombotic therapy after ischemic stroke
Short-term dual antiplatelet therapy (e.g., aspirin + clopidogrel) may be used in specific subsets, but long-term dual therapy has bleeding risk.
Anticoagulants (warfarin or DOACs such as rivaroxaban, apixaban) are chosen based on cardioembolic sources (e.g., AF) rather than all ischemic strokes.
Antiplatelets, statins, and lifestyle
After ischemic stroke, many patients are discharged on antiplatelets (e.g., aspirin) and often a statin; dual therapy decisions depend on etiology and risk.
Analgesia and management of secondary issues (pain, anxiety, depression) improve outcomes; TCAs/SNRIs may be used for mood disorders post-stroke depending on patient tolerance and interactions.
Hemorrhagic stroke and intracranial pressure (ICP) concerns
Hemorrhagic strokes include intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH).
In brain bleeds, expansion and raised ICP are critical concerns; signs of herniation include pupil changes, severe headache, vomiting, and decreasing consciousness.
Barriers to ICP increase: fixed skull, brain tissue swelling, restricted CSF flow; management aims to prevent brain herniation and maintain perfusion.
Elevating the head of the bed (to about 30 degrees) and keeping the patient midline helps venous drainage and ICP control; avoid sudden neck flexion or head turning that could impede drainage.
Invasive procedures (surgery, clipping, coiling for aneurysms) come with high risk; decisions are individualized.
Special topics and real-world practice pointers
Atrial fibrillation and PFO considerations: AF can be a source of cardioembolic strokes; PFO closure may be considered in select patients to reduce recurrent stroke risk.
Endarterectomy vs stenting: carotid interventions to reduce stroke risk vary by patient anatomy and comorbidity; risk of peri-procedural stroke exists.
Lipids and lifestyle: LDL reductions and HDL increases (e.g., via exercise) are important for long-term vascular health; the Mediterranean diet is emphasized.
TED hose vs SCDs for DVT prophylaxis in stroke patients: practice varies; SCDs are increasingly used in many settings; TED hose may be considered in some contexts.
NIH Stroke Scale (NIHSS) practical use: helps quantify stroke severity and track progress; not all elements must be perfect to document a deficit; focus on interactions and comprehension as well as motor signs.
Individualized patient education: stroke education should be tailored to the patient; avoid dumping information; provide actionable guidance and follow-up plans.
Practical tips for exam scenarios and clinical reasoning
Anchor on anatomy to reason through symptoms: if a stroke affects the left hemisphere, expect language deficits in a typical right-handed patient; if the right hemisphere, watch for neglect and emotional/impulse control changes.
Distinguish coordination vs weakness: dysarthria is a coordination issue (cerebellar or bulbar) rather than a primary motor weakness; true limb weakness points to motor cortex/frontal lobe involvement.
Aphasia testing requires both comprehension and expression checks; Wernicke’s aphasia makes following commands hard, Broca’s makes word production hard but comprehension may be preserved.
When assessing a patient with suspected stroke, prioritize time-sensitive decisions (thrombolysis eligibility, thrombectomy window) while continuing to collect imaging and clinical data.
If a patient cannot communicate well (aphasia or cognitive impairment), use open-ended questions, nonverbal cues, and visual instructions to gauge understanding and cooperation.
Quick recap of core ideas
TIAs are warning signals; most TIAs portend a stroke within days to weeks if risk factors aren’t controlled.
Ischemic strokes are most common; hemorrhagic strokes require rapid identification and different management.
Localization of deficits helps infer the brain areas involved and guides management.
Time is brain: reperfusion therapies (tPA/TNK and thrombectomy) rely on rapid imaging and decision-making.
Imaging and physiology (diffusion/perfusion, CTA/MRI) inform treatment windows and strategies.
Post-stroke care is multidisciplinary: BP control, glycemic control, lipid management, prevention of secondary injury, rehabilitation, and psychosocial support are essential for recovery.
Notes on terminology and context from the transcript
ABCD2 score and CHADS2 score were referenced as practical risk tools; the exact scoring rules follow standard medical guidelines.
TNK (tenecteplase) was highlighted as a faster, single-bolus alternative to alteplase (rt-PA) in specific clinical scenarios.
There was emphasis on “time vs tissue” and that the brain’s penumbra is salvageable tissue that we want to save; the dead core cannot be revived.
The speech-language and NIH exam content was described in practical, bedside terms to guide nursing and student performance.
Ethical and practical implications
Early and accurate stroke recognition saves lives and reduces disability.
Individualized care plans respect patient preferences and quality of life while balancing risks of therapies.
Communication with patients and families about prognosis, treatment options, and potential side effects is essential.
Ongoing education for clinicians and nursing staff improves outcomes, particularly in high-stress acute settings.
Quick reference formulas and numbers (LaTeX)
ABCD2 score components:
A = Age ≥ 60 → 1
B = Blood pressure at presentation ≥ 140/90 mmHg → 1
C = Clinical features: unilateral weakness → 2; speech impairment without weakness → 1
D = Duration: ≥ 60 minutes → 2; 10–59 minutes → 1
DM = Diabetes mellitus → 1
CHADS2 score components (for AF-related stroke risk):
CHF, Hypertension, Age ≥ 75, Diabetes, Stroke/TTIA (2 points)
Thrombolysis pharmacology (general reference):
Alteplase (rt-PA): with 10% given as bolus and 90% infused over 60 minutes.
Tenecteplase (TNK): typically a single bolus of .
:title Stroke and TIA: Comprehensive Study Notes
Note: These notes condense and organize the content from the provided transcript into a study-friendly form. They include major ideas, nuances, and practical points mentioned during the lecture, with key definitions and formulas presented in LaTeX where appropriate.